Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited scores highest on Price (68) and lowest on Earnings (12). Its PosiPenta is 29.86 out of 100, weaker than most similar companies.
On the Penta Grid this week, Balaxi Pharmaceuticals Limited is Grid #155 of 164 in the Healthcare sector in India, and Grid #2,123 of 2,328 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Balaxi Pharmaceuticals Limited | 29.86 | 68 | 12 | 13 | 28 | 27 |
| Krebs Biochemicals & Industries Limited | 36.07 | 0 | 2 | 48 | 100 | 30 |
| Par Drugs and Chemicals Limited | 54.63 | 98 | 46 | 19 | 71 | 39 |
| Bal Pharma Limited | 43.96 | 86 | 31 | 43 | 15 | 45 |
| Gujarat Inject (Kerala) Limited | 35.90 | 26 | 10 | 43 | 94 | 6 |
| CCME Global Limited | 27.16 | 29 | 8 | 6 | 51 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 49.09 |
| P/B ratio | 0.49 |
EEarnings
| Trailing EPS | ₹0.45 |
| Forward EPS | — |
NNitro
| Price | 22.09 |
| 52-week high | 43.85 |
| 52-week low | 15.20 |
| Fall from 52-week high | 49.6% |
TTorque
| Return on equity (ROE) (calculated) | 1.00% |
| Debt-to-equity | 0.23 |
AAnchor
| Beta (price swings) | 0.74 |
| Market cap | ₹121 Cr |
| Promoter holding | 65.99% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Balaxi Pharmaceuticals Limited's PosiPenta score?
Balaxi Pharmaceuticals Limited's PosiPenta is 29.86 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Balaxi Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Balaxi Pharmaceuticals Limited is Grid #155 of 164 in the Healthcare sector in India, and Grid #2,123 of 2,328 in India.
Which PosiPenta pillar is strongest for Balaxi Pharmaceuticals Limited?
Price (valuation), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Balaxi Pharmaceuticals Limited?
Earnings (growth), with a score of 12 out of 100: much weaker than most similar companies.
Has Balaxi Pharmaceuticals Limited's PosiPenta changed since last week?
Yes, it fell 1.03 points, from 30.89 to 29.86.
PositoAI is for research and education only and is not investment advice.